GB201515310D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB201515310D0
GB201515310D0 GBGB1515310.9A GB201515310A GB201515310D0 GB 201515310 D0 GB201515310 D0 GB 201515310D0 GB 201515310 A GB201515310 A GB 201515310A GB 201515310 D0 GB201515310 D0 GB 201515310D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1515310.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GBGB1515310.9A priority Critical patent/GB201515310D0/en
Publication of GB201515310D0 publication Critical patent/GB201515310D0/en
Priority to PCT/GB2016/052680 priority patent/WO2017033032A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1515310.9A 2015-08-27 2015-08-27 Pharmaceutical composition Ceased GB201515310D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1515310.9A GB201515310D0 (en) 2015-08-27 2015-08-27 Pharmaceutical composition
PCT/GB2016/052680 WO2017033032A1 (en) 2015-08-27 2016-08-30 Pharmaceutical composition for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1515310.9A GB201515310D0 (en) 2015-08-27 2015-08-27 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201515310D0 true GB201515310D0 (en) 2015-10-14

Family

ID=54326478

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1515310.9A Ceased GB201515310D0 (en) 2015-08-27 2015-08-27 Pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB201515310D0 (en)
WO (1) WO2017033032A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107320709A (en) * 2017-09-04 2017-11-07 上海市中医医院 A kind of Chinese medicine composition for treating asthma in children
JP2021527054A (en) * 2018-06-07 2021-10-11 キンデーバ ドラッグ デリバリー リミティド パートナーシップ Fluticasone and vilanterol preparations and inhalers
EP3880169A1 (en) * 2018-11-12 2021-09-22 Kindeva Drug Delivery L.P. Umeclidinium and vilanterol formulation and inhaler
CN117224482A (en) * 2023-09-07 2023-12-15 苏州易合医药有限公司 Inhalation preparation for treating IPF diseases and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
GB0525254D0 (en) * 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
GB0613161D0 (en) * 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
GB0918149D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
EP2804590A1 (en) * 2012-01-16 2014-11-26 Mahmut Bilgic Dry powder formulations comprising tiotropium and carmoterol
EP2804584A1 (en) * 2012-01-16 2014-11-26 Mahmut Bilgic Dry powder formulations comprising carmoterol and ciclesonide
EP2804585A1 (en) * 2012-01-16 2014-11-26 Mahmut Bilgic Dry powder formulations comprising tiotropium, formoterol and budesonide

Also Published As

Publication number Publication date
WO2017033032A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
IL265360B (en) Pharmaceutical composition
IL265260B (en) Pharmaceutical composition
GB201409471D0 (en) Pharmaceutical composition
IL262654A (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
PL3278801T3 (en) Pharmaceutical composition containing mirabegron
GB201506526D0 (en) Medicinal composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (en) Pharmaceutical compositions
PL3454838T3 (en) Pharmaceutical composition
GB201615917D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
HUE050881T2 (en) Pharmaceutical composition
IL265436B (en) Pharmaceutical composition
HUE057830T2 (en) Pharmaceutical composition comprising famitinib
GB2529605B (en) Pharmaceutical composition
IL265428A (en) Pharmaceutical composition
PT3476391T (en) Pharmaceutical composition
GB201620517D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)